Katja Hatz

1.1k total citations
40 papers, 617 citations indexed

About

Katja Hatz is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Katja Hatz has authored 40 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Ophthalmology, 32 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Katja Hatz's work include Retinal Diseases and Treatments (38 papers), Retinal Imaging and Analysis (28 papers) and Retinal and Optic Conditions (17 papers). Katja Hatz is often cited by papers focused on Retinal Diseases and Treatments (38 papers), Retinal Imaging and Analysis (28 papers) and Retinal and Optic Conditions (17 papers). Katja Hatz collaborates with scholars based in Switzerland, Austria and Germany. Katja Hatz's co-authors include Christian Prünte, Martin S. Zinkernagel, Chantal Dysli, Sebastián Wolf, Christian Pruente, Andreas Wenzel, Jan Studnička, Hanspeter E. Killer, Sajjad Mahmood and João Figueira and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Investigative Ophthalmology & Visual Science.

In The Last Decade

Katja Hatz

38 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katja Hatz Switzerland 12 563 428 76 32 31 40 617
Xiran Zhuang China 8 344 0.6× 252 0.6× 63 0.8× 46 1.4× 28 0.9× 10 414
Nevbahar Tamçelik Türkiye 14 418 0.7× 335 0.8× 88 1.2× 31 1.0× 37 1.2× 31 499
Simone de Voogd Netherlands 10 452 0.8× 325 0.8× 34 0.4× 16 0.5× 37 1.2× 10 483
Martin Šín Czechia 10 269 0.5× 195 0.5× 37 0.5× 45 1.4× 22 0.7× 31 323
Seung Hyen Lee South Korea 16 961 1.7× 809 1.9× 59 0.8× 21 0.7× 55 1.8× 33 976
Aziz A. Khanifar United States 9 479 0.9× 361 0.8× 75 1.0× 19 0.6× 16 0.5× 14 516
Reetika Sharma India 13 343 0.6× 246 0.6× 35 0.5× 20 0.6× 26 0.8× 33 398
Gavin Tan Singapore 9 311 0.6× 251 0.6× 23 0.3× 33 1.0× 33 1.1× 25 351
George Shafranov United States 8 515 0.9× 339 0.8× 46 0.6× 46 1.4× 60 1.9× 10 570
Maribel López-Gálvez Spain 5 382 0.7× 296 0.7× 83 1.1× 17 0.5× 6 0.2× 8 434

Countries citing papers authored by Katja Hatz

Since Specialization
Citations

This map shows the geographic impact of Katja Hatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Hatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Hatz more than expected).

Fields of papers citing papers by Katja Hatz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katja Hatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Hatz. The network helps show where Katja Hatz may publish in the future.

Co-authorship network of co-authors of Katja Hatz

This figure shows the co-authorship network connecting the top 25 collaborators of Katja Hatz. A scholar is included among the top collaborators of Katja Hatz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katja Hatz. Katja Hatz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michels, Stephan, et al.. (2024). Aflibercept high-dose (8mg) related intraocular inflammation (IOI) – a case series. BMC Ophthalmology. 24(1). 520–520. 8 indexed citations
2.
Somfai, Gábor Márk, Christoph Tappeiner, Katja Hatz, et al.. (2024). Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study. Pharmaceuticals. 17(9). 1235–1235. 1 indexed citations
3.
Mulyukov, Zufar, Pearse A. Keane, Jayashree Sahni, et al.. (2024). Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study. SHILAP Revista de lepidopterología. 4(6). 100565–100565. 1 indexed citations
5.
Garweg, Justus G., C Blum, Chiara M. Eandi, et al.. (2023). Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects. Ophthalmology and Therapy. 12(2). 639–655. 8 indexed citations
7.
Faes, Livia, Peter M. Maloca, Katja Hatz, et al.. (2022). Transforming ophthalmology in the digital century—new care models with added value for patients. Eye. 37(11). 2172–2175. 3 indexed citations
8.
Augustin, Albert J., et al.. (2021). Assessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and Switzerland. Clinical ophthalmology. Volume 15. 3957–3967. 3 indexed citations
9.
10.
11.
Hatz, Katja, et al.. (2020). Contrast sensitivity and binocular reading speed best correlating with near distance vision‐related quality of life in bilateral nAMD. Ophthalmic and Physiological Optics. 40(6). 760–769. 16 indexed citations
12.
Hatz, Katja, Frank Zimmermann, Dimitrios Kardamakis, et al.. (2020). Microvascular abnormalities and long-term efficacy after stereotactic radiotherapy under continued intravitreal anti-VEGF treatment for neovascular AMD. British Journal of Ophthalmology. 106(3). 415–421. 1 indexed citations
13.
Hatz, Katja, Roger Lehmann, Tilman Drescher, et al.. (2019). The prevalence of retinopathy in patients with type 1 diabetes treated with education-based intensified insulin therapy and its association with parameters of glucose control. Diabetes Research and Clinical Practice. 148. 234–239. 5 indexed citations
16.
Hatz, Katja & Christian Prünte. (2016). Changing from apro re natatreatment regimen to a treat and extend regimen with ranibizumab in neovascular age-related macular degeneration. British Journal of Ophthalmology. 100(10). 1341–1345. 31 indexed citations
17.
Hatz, Katja & Christian Prünte. (2016). INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB. Retina. 37(6). 1185–1192. 9 indexed citations
18.
Hatz, Katja & Christian Pruente. (2014). Treat and Extend regimen versus Pro Re Nata regimen in a comparative study of ranibizumab in exudative age-related macular degeneration: 12 months results. Investigative Ophthalmology & Visual Science. 55(13). 3931–3931. 1 indexed citations
19.
Pruente, Christian, et al.. (2009). A Randomized Double-masked Study Comparing Lucentis Monotherapy and PDT Combined With Lucentis Therapy in Patients With Exudative AMD: One Year Results for BCVA and Retreatment Frequency. Investigative Ophthalmology & Visual Science. 50(13). 5224–5224. 2 indexed citations
20.
Suter, Katja, et al.. (2008). Preservative-Free Triamcinolone Acetonide Suspension Developed for Intravitreal Injection. Journal of Ocular Pharmacology and Therapeutics. 24(1). 62–69. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026